EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Muscle pathology of antisynthetase syndrome according to antibody subtypes

Jantima Tanboon iD, Michio Inoue, Shinya Hirakawa, Hisateru Tachimori, Shinichiro Hayashi, Satoru Noguchi, Naoko Okiyama, Manabu Fujimoto, Shigeaki Suzuki, Ichizo Nishino iD

Brain Pathology · 2023-07 · 33 (4)

DOI: 10.1111/bpa.13155 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Brain Pathology, online erschienen am 07.03.2023. Verfasst von Jantima Tanboon und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo, Japan. Hauptthemen laut MEDLINE: Dermatomyositis, Myositis, Myositis, Inclusion Body. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Identification of antisynthetase syndrome (ASS) could be challenging due to inaccessibility and technical difficulty of the serology test for the less common non‐Jo‐1 antibodies. This study aimed to describe ASS antibody‐specific myopathology and evaluate the diagnostic utility of myofiber HLA‐DR expression. We reviewed 212 ASS muscle biopsies and compared myopathologic features among subtypes. Additionally, we compared their HLA‐DR staining pattern with 602 non‐ASS myositis and 140 genetically confirmed myopathies known to have an inflammatory component. We used t ‐test and Fisher's exact for comparisons and used sensitivity, specificity, positive and negative predictive values to assess the utility of HLA‐DR expression for ASS diagnosis. RNAseq performed from a subset of myositis cases and histologically normal muscle biopsies was used to evaluate interferon (IFN)‐signaling pathway‐related genes. Anti‐OJ ASS showed prominent myopathology with higher scores in muscle fiber (4.6 ± 2.0 vs. 2.8 ± 1.8, p = 0.001) and inflammatory domains (6.8 ± 3.2 vs. 4.5 ± 2.9, p = 0.006) than non‐OJ ASS. HLA‐DR expression and IFN‐γ‐related genes upregulation were prominent in ASS and inclusion body myositis (IBM). When dermatomyositis and IBM were excluded, HLA‐DR expression was 95.4% specific and 61.2% sensitive for ASS with a positive predictive value of 85.9% and a negative predictive value of 84.2%; perifascicular HLA‐DR pattern is common in anti‐Jo‐1 ASS than non‐Jo‐1 ASS (63.1% vs. 5.1%, p < 0.0001). In the appropriate clinicopathological context, myofiber HLA‐DR expression help support ASS diagnosis. The presence of HLA‐DR expression suggests involvement of IFN‐γ in the pathogenesis of ASS, though the detailed mechanisms have yet to be elucidated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DermatomyositisMyositisMyositis, Inclusion BodyHumansHLA-DR AntigensMuscle Fibers, SkeletalAutoantibodies

Stichwörter der Autor:innen

HLA-DRMHC class IIantisynthetase syndromeinflammatory myopathymuscle biopsymuscle pathology

Substanzen

HLA-DR AntigensAutoantibodies

Autor:innen und Institutionen

  • Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo, Japan.
  • Department of Genome Medicine Development, Medical Genome Center, National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo, Japan.
  • Department of Clinical Data Science, Clinical Research & Education Promotion Division, National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo, Japan.
  • Department of Dermatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
  • Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
  • Department of Dermatology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.

ORCID-Profile: Jantima Tanboon, Ichizo Nishino

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Tanboon, J., Inoue, M., Hirakawa, S., Tachimori, H., Hayashi, S., Noguchi, S., Okiyama, N., Fujimoto, M., Suzuki, S., & Nishino, I. (2023). Muscle pathology of antisynthetase syndrome according to antibody subtypes. Brain Pathology, 33(4). https://doi.org/10.1111/bpa.13155

Vancouver

Tanboon J, Inoue M, Hirakawa S, Tachimori H, Hayashi S, Noguchi S, et al. Muscle pathology of antisynthetase syndrome according to antibody subtypes. Brain Pathology. 2023;33(4). doi:10.1111/bpa.13155

BibTeX
@article{Tanboon2023,
  author = {Tanboon, Jantima and Inoue, Michio and Hirakawa, Shinya and Tachimori, Hisateru and Hayashi, Shinichiro and Noguchi, Satoru and Okiyama, Naoko and Fujimoto, Manabu and Suzuki, Shigeaki and Nishino, Ichizo},
  title = {Muscle pathology of antisynthetase syndrome according to antibody subtypes},
  journal = {Brain Pathology},
  year = {2023},
  volume = {33},
  number = {4},
  doi = {10.1111/bpa.13155}
}
Kostenlos starten →